A mass in the stomach refers to an abnormal growth or lump, which could be benign (non-cancerous) or malignant (cancerous). It may present with symptoms such as pain, bloating, or unexplained weight loss. Diagnostic tests like imaging or a biopsy are essential for determining the nature of the mass and whether surgical removal or further treatment is required.

Common VSG side effects include nausea, vomiting, acid reflux, and constipation due to the smaller stomach size. Nutrient deficiencies, like vitamin B12 and iron, may occur if patients don't follow their prescribed supplements. Long-term complications can include weight regain or the development of gastroesophageal reflux disease (GERD).

Gastritis can sometimes cause referred pain that radiates to the back, although this is not a common symptom. If a patient experiences back pain along with gastritis symptoms like nausea, bloating, or indigestion, it could indicate a more severe condition or complications such as ulcers.

Gastric sleeve results are typically impressive, with patients losing 50-60% of their excess body weight within the first year. The surgery also leads to improvements in obesity-related conditions like diabetes, hypertension, and sleep apnea. Long-term success depends on the patient’s ability to maintain a healthy lifestyle post-surgery.

A gastric specialist is a doctor who focuses on diagnosing and treating conditions affecting the stomach and digestive system. This includes conditions like ulcers, gastritis, acid reflux, and cancers of the stomach. These specialists may perform endoscopies and recommend lifestyle changes, medications, or surgery.

The Orbera gastric balloon is a non-surgical, temporary weight-loss device placed in the stomach to reduce food intake. The balloon is inflated and left in place for six months. During that time, patients follow a strict diet and exercise regimen to lose weight. It’s a popular choice for patients who want to avoid invasive surgery.

Semaglutide is a weight-loss medication that mimics a hormone regulating appetite and food intake. In the UK, it is marketed under the brand names Ozempic (for diabetes) and Wegovy (for obesity). It is prescribed to individuals struggling with weight management, often in conjunction with diet and exercise.

A partial gastrectomy is a surgical procedure where part of the stomach is removed, often due to stomach cancer, ulcers, or other severe gastric issues. This procedure reduces the size of the stomach, leading to reduced food intake, but it also requires significant dietary changes after surgery.

The gastric balloon pill is a new, non-invasive weight-loss method where a deflated balloon is swallowed in pill form and then inflated in the stomach. Known as the Allurion Balloon, this method reduces the amount of food the stomach can hold, promoting weight loss without surgery.

Gastric RNY, or Roux-en-Y gastric bypass, remains one of the most effective surgical options for treating obesity. By reducing the size of the stomach and bypassing a portion of the intestines, patients experience a significant reduction in hunger and an inability to eat large meals. Gastric RNY can lead to rapid weight loss and improvement or resolution of obesity-related conditions such as type 2 diabetes, sleep apnea, and hypertension.

Wegovy is available through the NHS for patients meeting specific criteria. To qualify, individuals generally need to have a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as diabetes or hypertension. Wegovy is a relatively new option and is prescribed under careful medical supervision.

A gastroenterologist is a specialist in diagnosing and treating diseases of the gastrointestinal tract, including the stomach, intestines, liver, pancreas, and gallbladder. Common conditions treated include IBS, Crohn's disease, and gastritis. They play a critical role in the care of patients post-bariatric surgery, helping manage complications and ensuring proper digestion.

Gastric band tablets are not a recognized treatment, but the term might refer to weight-loss medications that mimic the effects of a gastric band by suppressing appetite or blocking fat absorption. Medications like Orlistat or appetite suppressants are sometimes used in combination with bariatric procedures.

Pregnancy after weight-loss surgery is generally safe, but it’s recommended to wait at least 12-18 months after bariatric surgery before trying to conceive. This waiting period allows the body to stabilize and ensures proper nutrition for both the mother and baby. Women should work closely with their doctors to monitor their nutritional intake and ensure they are getting adequate vitamins and minerals during pregnancy.

Sleeve surgery is another term for the gastric sleeve procedure, where most of the stomach is removed to help patients achieve significant weight loss. The procedure is less invasive than other forms of bariatric surgery, like the Roux-en-Y bypass, but still offers dramatic weight-loss results.